Fennec Pharmaceuticals Inc (FENC)
11.38
+0.30
(+2.66%)
USD |
NASDAQ |
Mar 28, 10:01
Fennec Pharmaceuticals Profit Margin (Quarterly): -28.66% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -28.66% |
June 30, 2023 | -163.7% |
March 31, 2023 | -360.9% |
December 31, 2022 | -446.7% |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | -1.90K% |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 |
Date | Value |
---|---|
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.90K%
Minimum
Dec 2020
-28.66%
Maximum
Sep 2023
-580.9%
Average
-360.9%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
Pfizer Inc | -23.64% |
OptiNose Inc | -50.17% |
NovaBay Pharmaceuticals Inc | -53.81% |
Palatin Technologies Inc | -385.6% |
iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Assets | -85.94% |
Return on Invested Capital | -102.8% |
Gross Profit Margin (Quarterly) | 94.92% |
Operating Margin (Quarterly) | -16.72% |